Company
VRTX · CIK 0000875320
Acquisition (code A) of 8,682 shares at $0 per share.
Reporting Person van Grunsven Jasper · Officer Title EVP, CP and NPPO · Transaction Code A
Traded Sep 8, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0000875320-26-000272 · filed 2026-09-10 · View filing →
Sale.
Filer David Taylor · Chamber House · District OH02 · Transaction Type Sale · Asset Type Stock
Traded Aug 26, 2026 · Disclosed Sep 5, 2026FILED +10 DAYS
Source: House Clerk PTR · 20035392 · filed 2026-09-05 · View filing →
Sale (Full).
Filer David J. Taylor · Chamber House · District OH02 · Transaction Type Sale (Full) · Asset Type Stock
Traded Aug 25, 2026 · Disclosed Sep 5, 2026FILED +11 DAYS
Source: House Clerk PTR · 20035392 · filed 2026-09-05 · View filing →
Acquisition (code A) of 5,000 shares at $0 per share.
Reporting Person Ambrose Kristen · Officer Title SVP & Chief Accounting Officer · Transaction Code A
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0000875320-26-000267 · filed 2026-09-01 · View filing →
Purchase.
Filer Alan Armstrong · Chamber Senate · Owner Joint · Transaction Type Purchase · Asset Type Stock
Traded Mar 27, 2026 · Disclosed Jul 21, 2026FILED +116 DAYS
Source: Senate eFD PTR · fda235b3-bad7-4637-8fa1-053f354d929c · filed 2026-07-21 · View filing →
Purchase.
Filer Alan Armstrong · Chamber Senate · Owner Joint · Transaction Type Purchase · Asset Type Stock
Traded Mar 27, 2026 · Disclosed Jul 21, 2026FILED +116 DAYS
Source: Senate eFD PTR · fda235b3-bad7-4637-8fa1-053f354d929c · filed 2026-07-21 · View filing →
Purchase.
Filer Ro Khanna · Chamber House · District CA17 · Owner Spouse · Transaction Type Purchase · Asset Type Stock
Traded Apr 13, 2026 · Disclosed May 11, 2026FILED +28 DAYS
Source: House Clerk PTR · 9115822 · filed 2026-05-11 · View filing →
VERTEX PHARMACEUTICALS INC / MA